Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Takotsubo Cardiomyopathy | 2 | 2018 | 453 | 0.89 | Why? |
| Acute Coronary Syndrome | 5 | 2021 | 2107 | 0.85 | Why? |
| Heart Failure | 7 | 2020 | 6638 | 0.77 | Why? |
| Pericardiocentesis | 1 | 2018 | 84 | 0.72 | Why? |
| Echocardiography, Doppler | 1 | 2019 | 269 | 0.67 | Why? |
| Image Enhancement | 1 | 2018 | 177 | 0.65 | Why? |
| Cardiac Output | 1 | 2017 | 183 | 0.63 | Why? |
| Ultrasonography, Doppler | 2 | 2021 | 406 | 0.62 | Why? |
| Cardiac Tamponade | 1 | 2018 | 165 | 0.60 | Why? |
| Ventricular Function, Right | 1 | 2019 | 388 | 0.59 | Why? |
| Ultrasonography | 9 | 2020 | 4409 | 0.56 | Why? |
| Non-ST Elevated Myocardial Infarction | 2 | 2020 | 490 | 0.54 | Why? |
| Echocardiography | 5 | 2020 | 3661 | 0.53 | Why? |
| Nitric Oxide | 1 | 2020 | 769 | 0.51 | Why? |
| Shock, Cardiogenic | 1 | 2020 | 700 | 0.50 | Why? |
| Pacemaker, Artificial | 1 | 2017 | 431 | 0.48 | Why? |
| Shock | 1 | 2019 | 1868 | 0.46 | Why? |
| Myocardial Ischemia | 1 | 2017 | 781 | 0.41 | Why? |
| Heart | 1 | 2020 | 1791 | 0.41 | Why? |
| Cardiology | 3 | 2020 | 2873 | 0.38 | Why? |
| Venous Thromboembolism | 3 | 2020 | 4273 | 0.34 | Why? |
| Extracorporeal Membrane Oxygenation | 5 | 2020 | 5002 | 0.33 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.33 | Why? |
| Critical Illness | 2 | 2020 | 17281 | 0.31 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.29 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.27 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.26 | Why? |
| Vascular Surgical Procedures | 3 | 2021 | 882 | 0.26 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.25 | Why? |
| Syndrome | 2 | 2018 | 1310 | 0.24 | Why? |
| Respiratory Insufficiency | 3 | 2020 | 7301 | 0.24 | Why? |
| Arteries | 2 | 2021 | 283 | 0.23 | Why? |
| Thrombosis | 3 | 2021 | 7504 | 0.23 | Why? |
| Heart Rate | 2 | 2020 | 1527 | 0.20 | Why? |
| Acute Disease | 5 | 2021 | 6029 | 0.20 | Why? |
| Hemodynamics | 2 | 2018 | 1562 | 0.19 | Why? |
| Stress Disorders, Traumatic, Acute | 1 | 2021 | 141 | 0.19 | Why? |
| Sternum | 1 | 2018 | 30 | 0.19 | Why? |
| Diastole | 1 | 2019 | 168 | 0.19 | Why? |
| Respiration, Artificial | 4 | 2020 | 22116 | 0.19 | Why? |
| Lower Extremity | 2 | 2021 | 593 | 0.19 | Why? |
| Perfusion | 1 | 2019 | 254 | 0.18 | Why? |
| Systole | 1 | 2019 | 252 | 0.18 | Why? |
| Propafenone | 1 | 2017 | 2 | 0.18 | Why? |
| Metoprolol | 1 | 2017 | 42 | 0.17 | Why? |
| Heart Conduction System | 1 | 2020 | 266 | 0.17 | Why? |
| Tachycardia, Supraventricular | 1 | 2017 | 52 | 0.17 | Why? |
| Coronary Sinus | 1 | 2017 | 41 | 0.16 | Why? |
| Expert Testimony | 1 | 2020 | 658 | 0.16 | Why? |
| Echocardiography, Transesophageal | 2 | 2018 | 447 | 0.16 | Why? |
| Reference Values | 1 | 2019 | 795 | 0.16 | Why? |
| Amiodarone | 1 | 2017 | 110 | 0.15 | Why? |
| Pleura | 1 | 2017 | 178 | 0.15 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.15 | Why? |
| Abscess | 1 | 2018 | 234 | 0.15 | Why? |
| Venous Thrombosis | 2 | 2021 | 2739 | 0.15 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.15 | Why? |
| Humans | 41 | 2022 | 930598 | 0.14 | Why? |
| Catheterization, Central Venous | 1 | 2020 | 458 | 0.14 | Why? |
| Hemofiltration | 1 | 2016 | 155 | 0.14 | Why? |
| Italy | 9 | 2021 | 38444 | 0.14 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.14 | Why? |
| Anti-Arrhythmia Agents | 1 | 2017 | 325 | 0.13 | Why? |
| Fibrinogen | 1 | 2020 | 1048 | 0.13 | Why? |
| Stress, Psychological | 1 | 2017 | 10231 | 0.13 | Why? |
| Prosthesis-Related Infections | 1 | 2018 | 302 | 0.13 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.13 | Why? |
| Malaysia | 1 | 2018 | 1116 | 0.13 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.13 | Why? |
| Fluid Therapy | 1 | 2018 | 628 | 0.13 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.13 | Why? |
| Ventricular Dysfunction, Right | 1 | 2020 | 639 | 0.13 | Why? |
| Endocarditis, Bacterial | 1 | 2018 | 344 | 0.12 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.12 | Why? |
| Heart Valve Prosthesis | 1 | 2018 | 533 | 0.12 | Why? |
| Long QT Syndrome | 1 | 2022 | 1047 | 0.12 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2018 | 552 | 0.11 | Why? |
| Surgery Department, Hospital | 1 | 2021 | 954 | 0.11 | Why? |
| Biopsy | 1 | 2020 | 2811 | 0.11 | Why? |
| Endovascular Procedures | 1 | 2020 | 1302 | 0.11 | Why? |
| Precision Medicine | 1 | 2020 | 1477 | 0.10 | Why? |
| Risk Assessment | 5 | 2020 | 25439 | 0.10 | Why? |
| Natriuretic Peptide, Brain | 1 | 2016 | 1215 | 0.10 | Why? |
| Middle Aged | 14 | 2022 | 270681 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Male | 17 | 2022 | 367725 | 0.09 | Why? |
| Consensus | 2 | 2020 | 6345 | 0.09 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.09 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.09 | Why? |
| Female | 17 | 2022 | 380317 | 0.09 | Why? |
| Patient Positioning | 1 | 2018 | 1505 | 0.09 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.09 | Why? |
| Aged | 13 | 2022 | 215776 | 0.08 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.08 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.08 | Why? |
| Computed Tomography Angiography | 1 | 2017 | 2153 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Azithromycin | 1 | 2022 | 3943 | 0.08 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.08 | Why? |
| Peptide Fragments | 1 | 2016 | 2075 | 0.08 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2020 | 3051 | 0.07 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.07 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.07 | Why? |
| Aged, 80 and over | 9 | 2022 | 88759 | 0.07 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2021 | 2963 | 0.07 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.07 | Why? |
| Europe | 2 | 2020 | 12702 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.06 | Why? |
| Cause of Death | 1 | 2016 | 4823 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Adult | 8 | 2022 | 244371 | 0.06 | Why? |
| Electrocardiography | 3 | 2022 | 3957 | 0.06 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.06 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.06 | Why? |
| Ideal Body Weight | 1 | 2020 | 18 | 0.05 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Percutaneous Coronary Intervention | 1 | 2018 | 3646 | 0.05 | Why? |
| Lung | 6 | 2020 | 31049 | 0.05 | Why? |
| Angiography | 1 | 2021 | 301 | 0.05 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3832 | 0.05 | Why? |
| Action Potentials | 1 | 2020 | 368 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Amputation | 1 | 2021 | 331 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2022 | 12447 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| Risk Factors | 5 | 2022 | 71621 | 0.03 | Why? |
| Electric Countershock | 1 | 2017 | 284 | 0.03 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| Positive-Pressure Respiration | 1 | 2020 | 1160 | 0.03 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.03 | Why? |
| Thrombectomy | 1 | 2021 | 2272 | 0.02 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.02 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.02 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2016 | 9537 | 0.01 | Why? |
| Registries | 1 | 2020 | 12327 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Tavazzi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(227)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_